Abstract
The risk of malignant non-Hodgkin lymphoma is increased in primary Sjögren syndrome. In the literature, most studies evaluating this risk were conducted in tertiary reference university hospital. So, selection bias in series exists, in particular selection of the most severe cases in tertiary reference university care centers. Some studies had also a selection bias because patients were hospitalized (data were obtained from hospital discharge registries) and therefore the more severe cases were considered. Between October 1999 and November 2009, 109 adult patients were admitted to our department of internal medicine (non-university hospital, secondary level of the healthcare system, hospitalized patients and outpatient) with diagnosis of primary Sjögren syndrome. Two cases of parotid gland lymphoma occurred during the period of follow-up. No other lymphoma was detected. In this study, clinically identifiable parotid gland non-Hodgkin lymphoma occurs in 1.8% of patients with primary Sjögren syndrome. Because most non-Hodgkin lymphoma initially involves the neck organs, meticulous imaging studies mainly focused on the cervical regions are recommended in the follow-up of patients with primary Sjögren syndrome. Patients whose main complaint is persistent parotid gland swelling may have a parotid biopsy in order to diagnose non-Hodgkin lymphoma.
This is a preview of subscription content, log in via an institution to check access.
References
Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 164:1275–1284
Vitali C, Bombardieri S, Jonsson R et al (2002) European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American European Consensus Group. Ann Rheum Dis 61:482–484
Kassan SS, Thomas TL, Moutsopoulos HM et al (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888–892
Theander E, Henriksson G, Ljunberg O et al (2006) Lymphoma and other malignancies in primary Sjogren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796–803
Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337–2344
Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM (2009) Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88:284–293
Ramos-Casals M, Brito-Zeron P, Perez-de-Lis M et al (2010) Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren’s syndrome. J Rheumatol 37:585–590
Anderson LA, Gadalla S, Morton LM et al (2009) Population-based study of auto-immune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125:398–405
Ekström Smedby K, Hjalgrim H, Askling J et al (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98:51–60
Ekström-Smedby K, Vajdic CM, Falster M et al (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111:4029–4038
Zhang W, Feng S, Yan S et al (2010) Incidence of malignancy in primary Sjögren’s syndrome in a Chinese cohort. Rheumatology (Oxford) 49:571–577
Conflict of interests
No conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zenone, T. Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome. Rheumatol Int 32, 1387–1390 (2012). https://doi.org/10.1007/s00296-011-1851-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-1851-9